These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 29281822)

  • 41. DNA Unwinding Is the Primary Determinant of CRISPR-Cas9 Activity.
    Gong S; Yu HH; Johnson KA; Taylor DW
    Cell Rep; 2018 Jan; 22(2):359-371. PubMed ID: 29320733
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The Conformational Dynamics of Cas9 Governing DNA Cleavage Are Revealed by Single-Molecule FRET.
    Yang M; Peng S; Sun R; Lin J; Wang N; Chen C
    Cell Rep; 2018 Jan; 22(2):372-382. PubMed ID: 29320734
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Engineering the Delivery System for CRISPR-Based Genome Editing.
    Glass Z; Lee M; Li Y; Xu Q
    Trends Biotechnol; 2018 Feb; 36(2):173-185. PubMed ID: 29305085
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Rapid and Scalable Characterization of CRISPR Technologies Using an E. coli Cell-Free Transcription-Translation System.
    Marshall R; Maxwell CS; Collins SP; Jacobsen T; Luo ML; Begemann MB; Gray BN; January E; Singer A; He Y; Beisel CL; Noireaux V
    Mol Cell; 2018 Jan; 69(1):146-157.e3. PubMed ID: 29304331
    [TBL] [Abstract][Full Text] [Related]  

  • 45. RNA-targeting CRISPR comes of age.
    Kim VN
    Nat Biotechnol; 2018 Jan; 36(1):44-45. PubMed ID: 29319696
    [No Abstract]   [Full Text] [Related]  

  • 46. Bacterial RNA Biology on a Genome Scale.
    Hör J; Gorski SA; Vogel J
    Mol Cell; 2018 Jun; 70(5):785-799. PubMed ID: 29358079
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Incomplete prophage tolerance by type III-A CRISPR-Cas systems reduces the fitness of lysogenic hosts.
    Goldberg GW; McMillan EA; Varble A; Modell JW; Samai P; Jiang W; Marraffini LA
    Nat Commun; 2018 Jan; 9(1):61. PubMed ID: 29302058
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Thermo-triggered Release of CRISPR-Cas9 System by Lipid-Encapsulated Gold Nanoparticles for Tumor Therapy.
    Wang P; Zhang L; Zheng W; Cong L; Guo Z; Xie Y; Wang L; Tang R; Feng Q; Hamada Y; Gonda K; Hu Z; Wu X; Jiang X
    Angew Chem Int Ed Engl; 2018 Feb; 57(6):1491-1496. PubMed ID: 29282854
    [TBL] [Abstract][Full Text] [Related]  

  • 49. A beginner's guide to gene editing.
    Harrison PT; Hart S
    Exp Physiol; 2018 Apr; 103(4):439-448. PubMed ID: 29282799
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Identifying Novel Enhancer Elements with CRISPR-Based Screens.
    Klein JC; Chen W; Gasperini M; Shendure J
    ACS Chem Biol; 2018 Feb; 13(2):326-332. PubMed ID: 29300083
    [TBL] [Abstract][Full Text] [Related]  

  • 51. RNA-dependent RNA targeting by CRISPR-Cas9.
    Strutt SC; Torrez RM; Kaya E; Negrete OA; Doudna JA
    Elife; 2018 Jan; 7():. PubMed ID: 29303478
    [TBL] [Abstract][Full Text] [Related]  

  • 52. APOBEC3 induces mutations during repair of CRISPR-Cas9-generated DNA breaks.
    Lei L; Chen H; Xue W; Yang B; Hu B; Wei J; Wang L; Cui Y; Li W; Wang J; Yan L; Shang W; Gao J; Sha J; Zhuang M; Huang X; Shen B; Yang L; Chen J
    Nat Struct Mol Biol; 2018 Jan; 25(1):45-52. PubMed ID: 29323274
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Scarless Genome Editing of Human Pluripotent Stem Cells via Transient Puromycin Selection.
    Steyer B; Bu Q; Cory E; Jiang K; Duong S; Sinha D; Steltzer S; Gamm D; Chang Q; Saha K
    Stem Cell Reports; 2018 Feb; 10(2):642-654. PubMed ID: 29307579
    [TBL] [Abstract][Full Text] [Related]  

  • 54. With a free pass, CRISPR-edited plants reach market in record time.
    Waltz E
    Nat Biotechnol; 2018 Jan; 36(1):6-7. PubMed ID: 29319694
    [No Abstract]   [Full Text] [Related]  

  • 55. Development of versatile non-homologous end joining-based knock-in module for genome editing.
    Sawatsubashi S; Joko Y; Fukumoto S; Matsumoto T; Sugano SS
    Sci Rep; 2018 Jan; 8(1):593. PubMed ID: 29330493
    [TBL] [Abstract][Full Text] [Related]  

  • 56. A Survey of Validation Strategies for CRISPR-Cas9 Editing.
    Sentmanat MF; Peters ST; Florian CP; Connelly JP; Pruett-Miller SM
    Sci Rep; 2018 Jan; 8(1):888. PubMed ID: 29343825
    [TBL] [Abstract][Full Text] [Related]  

  • 57. In vivo simultaneous transcriptional activation of multiple genes in the brain using CRISPR-dCas9-activator transgenic mice.
    Zhou H; Liu J; Zhou C; Gao N; Rao Z; Li H; Hu X; Li C; Yao X; Shen X; Sun Y; Wei Y; Liu F; Ying W; Zhang J; Tang C; Zhang X; Xu H; Shi L; Cheng L; Huang P; Yang H
    Nat Neurosci; 2018 Mar; 21(3):440-446. PubMed ID: 29335603
    [TBL] [Abstract][Full Text] [Related]  

  • 58. A Cleavage-Responsive Stem-Loop Hairpin for Assaying Guide RNA Activity.
    deBoer TR; Wauford N; Chung JY; Torres Perez MS; Murthy N
    ACS Chem Biol; 2018 Feb; 13(2):461-466. PubMed ID: 29381046
    [TBL] [Abstract][Full Text] [Related]  

  • 59. A Universal Protocol for Large-scale gRNA Library Production from any DNA Source.
    Köferle A; Stricker SH
    J Vis Exp; 2017 Dec; (130):. PubMed ID: 29286403
    [TBL] [Abstract][Full Text] [Related]  

  • 60. A Protocol for the Production of Integrase-deficient Lentiviral Vectors for CRISPR/Cas9-mediated Gene Knockout in Dividing Cells.
    Vijayraghavan S; Kantor B
    J Vis Exp; 2017 Dec; (130):. PubMed ID: 29286484
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.